Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval crawled time : 15:00 save search
Basilea Wins FDA Approval for Antibiotic Ending 15-Year Regulatory Quest
Published: 2024-04-04 (Crawled : 15:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
fda approval
Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is Needed
Published: 2024-03-20 (Crawled : 15:00) - globenewswire.com
SCLX | $0.8407 -13.92% -16.18% 1.7M
|
|
| O: 0.0%
H: 3.7%
C: 0.74%
gloperba fda label company renal approval
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
Published: 2024-03-12 (Crawled : 15:00) - globenewswire.com
NCAC | $4.79 3.13% 21K
|
| Email alert
Add to watchlist
nasdaq approval research
Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
Published: 2024-03-08 (Crawled : 15:00) - biospace.com/
SENS | $0.433 0.7% 0.0% 1.4M
|
Electronic Technology
|
| O: 1.51%
H: 6.65%
C: 4.18%
eversense conference approval international advanced diabetes study
Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector
Published: 2024-03-01 (Crawled : 15:00) - biospace.com/
MNKKQ | $0.02
|
Manufacturing
| Email alert
Add to watchlist
MNK | $0.3402 -0.06% 540K
|
n/a
| Email alert
Add to watchlist
MNKPF | $17.25
|
n/a
| Email alert
Add to watchlist
MNKTQ | $0.12 -66.67% 39K
|
Manufacturing
| Email alert
Add to watchlist
acthar fda drug approval gel application
WuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance's AMTAGVI™ (lifileucel) for Advanced Melanoma
Published: 2024-02-20 (Crawled : 15:00) - biospace.com/
IOVA M | $11.69 -1.43% -1.45% 2.7M
|
Health Technology
|
| O: 27.32%
H: 15.11%
C: 3.26%
fda melanoma approval advanced
MustGrow Receives Registration Approval for TerraSante(TM) in Oregon State
Published: 2024-02-06 (Crawled : 15:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
state approval
Kite Receives U.S. FDA Approval of Manufacturing Process Change Resulting in Reduced Median Turnaround Time for Yescarta® CAR T-cell Therapy
Published: 2024-01-30 (Crawled : 15:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.34%
H: 0.13%
C: -0.23%
yescarta fda t-cell change approval therapy
Northann Corp. Receives Approval from U.S. Patent and Trademark Office for Core Technology in Benchwick 3D Printing Ecosystem
Published: 2024-01-17 (Crawled : 15:00) - globenewswire.com
NCL | $0.5288 -5.61% -0.59% 650K
|
|
| O: -1.87%
H: 11.43%
C: 8.57%
patent approval technology
Borr Drilling Limited - Approval of Share Repurchase Program
Published: 2023-12-08 (Crawled : 15:00) - prnewswire.com
BORR | $5.59 -3.12% 0.0% 1.7M
|
Industrial Services
|
| O: 2.43%
H: 5.26%
C: 4.92%
approval repurchase program
MustGrow Receives Registration Approval for TerraSante(TM) in Washington State
Published: 2023-11-15 (Crawled : 15:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
state approval
BioMarin Scores Expanded Approval for Dwarfism Treatment; Dupixent Suffers Ra...
Published: 2023-10-23 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -0.48%
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: -0.44%
H: 0.08%
C: -2.05%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.69%
H: 0.0%
C: 0.0%
dupixent approval
PSE&G Gains Approval to Continue Modernizing Its Gas System
Published: 2023-10-11 (Crawled : 15:00) - prnewswire.com
PEG | $67.23 1.11% 0.0% 3.3M
|
Utilities
|
| O: 0.3%
H: 2.69%
C: 2.6%
approval gas system
Amicus Therapeutics Announces FDA Approval and Launch of New Treatment for Pompe Disease
Published: 2023-09-28 (Crawled : 15:00) - globenewswire.com
FOLD 4 | $10.52 -1.77% -1.81% 1.6M
|
Health Technology
|
| O: -1.32%
H: 1.73%
C: -6.69%
fda disease approval treatment therapeutics
Takeda Announces Approval of CUVITRU™ Subcutaneous Immunoglobulin in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia
Published: 2023-09-25 (Crawled : 15:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 0.57%
H: 0.38%
C: 0.25%
japan approval
Ligand’s Partner Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze® (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Published: 2023-09-22 (Crawled : 15:00) - biospace.com/
LGND | $70.87 1.4% 1.38% 150K
|
Health Technology
|
| O: -0.07%
H: 1.1%
C: -0.34%
JAZZ | $108.38 -1.18% -1.19% 400K
|
Health Technology
|
| O: -0.02%
H: 0.89%
C: -0.72%
enrylaze approval treatment pharmaceuticals leukemia
IceCure Medical's ProSense Cryoablation System Receives Regulatory Approval in Brazil
Published: 2023-09-05 (Crawled : 15:00) - biospace.com/
ICCM | $1.22 0.82% 94K
|
Manufacturing
| Email alert
Add to watchlist
prosense approval system brazil
Elrexfio Gets Accelerated FDA Approval For Refractory Multiple Myeloma11 Bispecific Antibodies With Combine Sales Of More Than 3 Billion Are Approved In US Market Says Kuick Research
Published: 2023-08-16 (Crawled : 15:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
sales fda approved approval research market
MCRA Aids Surmodics in Obtaining FDA Pre-Market Approval for Cardiovascular Drug-Coated Balloon
Published: 2023-08-07 (Crawled : 15:00) - prnewswire.com
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: 0.59%
H: 3.16%
C: 1.61%
fda approval cardiovascular
Nymox's 3-month ex-CFO was Awarded an Unauthorized and Undisclosed Treasury Directive for 100,000 Shares of Nymox Stock Without the Knowledge or Approval of the Nymox Board or Nymox’s CEO
Published: 2023-07-31 (Crawled : 15:00) - globenewswire.com
NYMX | $0.2 -19.68% -23.88% 930K
|
Health Technology
| Email alert
Add to watchlist
ceo approval
Gainers vs Losers
| 65% | 35% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 210M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
ILAG | $0.51 6.03% 29.06% 430K
|
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.